Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 183 results found. Search for [ diabetes drug in India ]

Results 1 to 21 of 183
BusinessToday.In
May 12, 2021
The government said that it is engaging with manufacturers to ramp up production of the drug. Supply of Amphotericin B will be improved through an increase in production and extra imports


Reuters
April 30, 2021
This is the first time the Anglo-Swedish drugmaker has given financial details of the distribution and sales of its vaccine, which it developed with Oxford University


BusinessToday.In
April 29, 2021
The Centre clarified that asymptomatic cases are those that are confirmed so by the laboratories but are not experiencing any symptoms and have oxygen saturation at room air of more than 94 per cent


PB Jayakumar
March 31, 2021
Hemmo is one of the few pure-play synthetic peptide API manufacturers in the global marketplace. It has R&D capabilities and a world-class GMP manufacturing facility at Thurbhe in Navi Mumbai


PTI
March 24, 2021
Dr Murthy, 43, would occupy the position of America's Surgeon General for the second time. In 2011, president Barack Obama tapped him to serve on the advisory group on prevention, health promotion, and integrative and public health


BusinessToday.In
March 1, 2021
The government, in this phase, will vaccinate people over 60 and individuals over 45 with comorbidities to rein in the rising number of more infectious virus strains leading to a spurt in COVID-19 cases in some states


Rashi Bisaria
New Delhi, February 9, 2021
Bitcoin crosses $44,000 mark on $1.5 billion boost from TeslaBitcoin breached the $44,000 mark for the first time on Monday after Tesla revealed that it had invested around $1.5 billion in the cryptocurrency last month. The digital currency surged over 15 per cent after Elon Musk-led electric car manufacturer said that it is expected to begin accepting payment for its cars and other products with it in the near future.PM Modi dials Joe Biden, discusses regional, climate change issuesPrime ...


PTI
February 8, 2021
Astrazeneca has received marketing authorisation to use its anti-diabetic drug dapagliflozin for the treatment of patients with chronic kidney disease in India


BusinessToday.In
February 7, 2021
As per the USFDA report, the affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc.


PTI
February 7, 2021
The affected lot of the intramuscular injections was manufactured by the drug maker in India and distributed in the US by Princeton, New Jersey-based Sun Pharmaceutical Industries Inc


Vamsi Maddipatla
February 1, 2021
With a cohesive effort from both public and private players, the Indian bio-pharma industry has the potential to unlock tremendous growth over the next few years


BusinessToday.In
December 29, 2020
It is important from the scientific community perspective that we do not put too much immune pressure on the virus, said Bhargava


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


BusinessToday.In
October 30, 2020
India Stock Market Highlights Today: Global equities were buoyed today amid upbeat domestic economic data and rally in stocks in anticipation of better earnings reports


Aprajita Sharma
October 15, 2020
While insurers now see the physical and mental diseases from the same prism, the treatment of former is quite different from the latter


Joe C Mathew
October 13, 2020
In most cases, AstraZeneca gathered information about marketing approvals from the state departments by using the RTI (Right to Information Act) route


Reuters
September 12, 2020
The Food and Drug Administration has allowed more liberal remdesivir use, but 6 out of 8 major hospital systems contacted by Reuters said they were not using it for moderate cases


PB Jayakumar
September 2, 2020
Mankind has been promoting DrOnA Health among doctors as a service to help them. Over 10,000 doctors are now using the facility. Another special feature of the app is that it allows doctors to have complete ownership of data.


BusinessToday.In
September 1, 2020
Following the announcement, Biocon shares opened at Rs 382.05 and jumped 6.97% to its intraday high of Rs 402.65 against the last closing of Rs 376.40 on BSE. The stock trades near its 52-week high of Rs 455, hit on July 13, 2020


BusinessToday.In
September 1, 2020
India Stock Market Highlights Today: Eicher Motors, NTPC, Nestle, Power Grid and Bajaj Finserv were leading as top gainers. On the other hand, TCS, Maruti, ITC, Nestle, Infosys, Wipro, HCL Tech, Sun Pharma,  were among the top losers today.


PAGES 1 OF 10  12345